EU Horizon Europe - sök utlysningar inom medicin
På denna sida har vi samlat utlysningar inom EU:s ramprogram Horizon Europe som är särskilt intressanta för dig som är verksam vid Medicinska fakulteten.
Allmän information
Horisont Europa (Horzion Europe) är EU:s ramprogram för forskning och innovation för 2021–2027 med en total budget på nära 95,5 miljarder euro. Programmet är strukturerat kring tre prioriteringar: Vetenskaplig spetskompetens, Globala utmaningar och europeisk industriell konkurrenskraft samt Ett innovativt Europa. Inom dessa pelare finns en mängd olika utlysningar, där vissa har allmänna mål medan andra är mer avgränsade och riktade.
Utsnitt kopplat till Medicinska fakulteten
På denna sida hittar du en samling riktade utlysningar för samarbetsprojekt kopplade till forskningsområden vid Medicinska fakulteten, främst inom pelare II Globala utmaningar. Du kan koordinera ett förslag, men du kan också delta som partner. Ta gärna kontakt med ditt internationella nätverk för att hitta samarbetspartners som delar ditt intresseområde eller för att ansluta till pågående initiativ.
Stöd och frågor
Om du är intresserad och vill ha stöd i nästa steg, vänligen kontakta Lunds universitets Forskningsservice så tidigt som möjligt. Forskningsservice erbjuder stöd genom hela processen — från ansökan till genomfört projekt. Du får vägledning och hjälp att hitta lämpliga utlysningar. Du får också rådgivning om konsortiet, hur du matchar ditt projekt mot utlysningen, samt tips och mallar för ansökningsarbetet — både den administrativa delen och budgetarbetet — och hjälp med delar av ansökningstexten.
Om utlysningarna
De flesta finansieringsmöjligheterna finns inom Kluster 1 – Hälsa. Detta kluster stödjer forskning som främjar hälsa och välbefinnande för människor i alla åldrar genom att generera ny kunskap, utveckla innovativa lösningar och, där det är relevant, integrera ett genusperspektiv. Allt för att förebygga, diagnostisera, övervaka, behandla och bota sjukdomar.
Möjligheterna kräver internationella och samarbetsinriktade insatser och förväntas bidra till de fördefinierade utmaningarna som beskrivs i utlysningstexterna. Forskare som arbetar inom kliniska, biomedicinska, folkhälsovetenskapliga eller translationella områden samt digital hälsa hittar de mest relevanta utlysningarna här.
Hälsorelaterad forskning kan också finansieras genom EU-missionen om cancer, som omfattar hela cancerkontinuumet – från prevention och tidig upptäckt till behandling och livskvalitet.
Dessutom erbjuder flera europeiska partnerskap kopplade till Horisont Europa särskilda finansieringsmöjligheter för samarbetsdriven och tvärvetenskaplig hälsoforskning.
Öppna och planerade utlysningar:
- Kluster 1 – Hälsa
- Mission Cancer
- Partnerskapsprogram
- Europeiska innovationsrådet (pelare III)
- Andra möjligheter inom Horisont Europa programmet
Aktuella och kommande utlysningar
Läs mer om utlysningarna inom medicin och hälsa nedan, informationen är på engelska.
Call texts for below topics are found in this document:
Horizon Europe, Work Programme 2026-2027, 4. Health (PDF, 3 MB, new tab)
When open, calls are published through the EU Funding and Tenders Portal:
EU Funding and Tenders Portal
Calls with planned deadline in 2027
The links below will direct you to the correct page in the document above, unless you are using Microsoft Edge or if you are using another browser with an Adobe Acrobat extension. In those cases, either disable the extension or manually look up the page number after the link. The links will be opened in a new tab.
Addressing disabilities through the life course to support independent living and inclusion
HORIZON-HLTH-2027-01-STAYHLTH-01 (page 36)
Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change
HORIZON-HLTH-2027-01-ENVHLTH-02 (page 54)
MISSCLIMA-03: Tools and technologies to support health adaptation to climate change
HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03 (page 59)
Development of novel broad spectrum small molecule antiviral therapeutics for pathogens with epidemic potential
HORIZON-HLTH-2027-01-DISEASE-05 (page 104)
Development of monoclonal antibodies to prevent and treat infections from Flaviviruses HORIZON-HLTH-2027-01-DISEASE-06 (page 107)
Development of monoclonal antibodies to prevent and treat infections from Filo- Phenui-, Picorna- and Toga Viridae
HORIZON-HLTH-2027-01-DISEASE-07 (page 110)
Development of innovative antimicrobials or antibody-based therapies against critical pathogens resistant to antimicrobials (AMR)
HORIZON-HLTH-2027-01-DISEASE-08 (page 113)
Prevention and management of chronic non-communicable diseases in children and young people (GACD)
HORIZON-HLTH-2027-01-DISEASE-10 (page 116)
Clinical trials for advancing innovative interventions for neurodegenerative diseases
HORIZON-HLTH-2027-02-DISEASE-14-two-stage (page 121)
Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
HORIZON-HLTH-2027-01-CARE-02 (page 140)
Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic communicable diseases
HORIZON-HLTH-2027-01-TOOL-01 (page 162)
Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
HORIZON-HLTH-2027-03-TOOL-04 (page 169)
Cell-free protein synthesis platforms for discovery and/or production of biologicals
HORIZON-HLTH-2027-01-IND-01 (page 184)
Innovative healthcare interventions for non-communicable diseases
HORIZON-HLTH-2027-02-DISEASE-01-two-stage (page 99)
Portable and versatile Point-of-care diagnostics
HORIZON-HLTH-2027-02-IND-02-two-stage (page 187)
Advancing bio-printing of living cells for regenerative medicine
HORIZON-HLTH-2027-03-TOOL-02 (page 166)
In Work Programme 2026 and 2027 the calls below are planned.
Call texts for below topics are found in this document:
Horizon Europe, Work Programme 2026-2027, 12. Missions (PDF, 3 MB, new tab)
When open, calls are published through the EU Funding and Tenders Portal:
EU Funding and Tenders Portal
2026
Calls with deadline 15 September 2026.
The links below will direct you to the correct page in the Mission document, unless you are using Microsoft Edge or if you are using another browser with an Adobe Acrobat extension. In those cases, either disable the extension or manually look up the page number after the link. The links will be opened in a new tab.
Virtual Human Twin (VHT) Models for Cancer Research
HORIZON-MISS-2026-02-CANCER-01 (page 67)
Microbiome for early cancer prediction before onset of disease
HORIZON-MISS-2026-02-CANCER-02 (page 70)
Pragmatic clinical trials to optimise immunotherapeutic interventions for cancer patients with refractory cancerHORIZON-MISS-2026-02-CANCER-03 (page 72)
Earlier and more precise palliative care
HORIZON-MISS-2026-02-CANCER-04 (page 73)
Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)
HORIZON-MISS-2026-02-CANCER-05 (page 75)
Development of a capacity building programme on cancer research with and for Ukraine
HORIZON-MISS-2026-02-CANCER-06 (page 76)
Improve the Quality of Life of older cancer patients
HORIZON-MISS-2026-02-CANCER-07 (page 78)
2027
Call texts for the topics below are found in this document:
Annex XII Horizon Europe, Work Programme 2026-2027, 12. Missions (PDF, 3 MB, new tab)
Leveraging functional genomics to reveal novel targets for cancer treatment
HORIZON-MISS-2027-02-CANCER-01
Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers
HORIZON-MISS-2027-02-CANCER-02
Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
HORIZON-MISS-2027-02-CANCER-03
Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research HORIZON-MISS-2027-02-CANCER-04
Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines
HORIZON-MISS-2027-02-CANCER-05
Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agencies HORIZON-MISS-2027-02-CANCER-06
Below you find the European Partnerships and links to their websites where their opportunities can be found.
- Brain Health (EP BrainHeelth)
- Chemicals Risk Assessment (PARC website)
- ERA for Health
- Global Health Partnership (EDCTP3)
- Innovative Health Initiative (IHI JU)
- One-Health Antimicrobial Resistance (AMR)
- Pandemic Preparedness (Be ready)
- Personalised Medicine (EP PerMed)
- Rare Diseases (ERDERA)
- Transformation of Health Systems THCS
EIC Pathfinder Challenge - Biotechnology for Healthy Ageing
To develop biotechnology-based or pharmaceutical interventions that prevent, delay, or reverse age-related diseases. The Challenge will focus on advancing biotechnology for healthy ageing, promoting personalised care through molecular profiling, guiding policymakers and developers on regulatory approaches, and raising public awareness about healthy longevity. Deadline October 2026.
Go to EIC Pathfinder Challenges 2026 (EIC website)
EIC Bottom-up funding
- EIC Pathfinder Open (EIC website) Deadline 12 May, 2026.
- EIC Transition (EIC website) Deadline September 2026.
Research infrastructures (Pillar I)
The Research Infrastructures programme (RI) is thematically broad, but several topics may provide direct support to medical research, especially through access to data, biobanks, advanced instrumentation, or EU’s major medical research infrastructures (for example EBRAINS).
List of call topics and call texts are found in this document:
Horizon Europe Work Programme 2026-2027 3. Research Infrastructures (PDF, 914 kB, new tab)
Three examples of calls
The links below will be opened in a new tab.
- Implementing digital services to empower neuroscience research for health and brain inspired technology via EBRAINS
HORIZON-INFRA-2026-SERV-01-01 (page 58) - Research infrastructure concept development including major upgrades or extensions of existing infrastructures
HORIZON-INFRA-2026-DEV-01-01 (page 15) - Risk management, mitigation and contingency for ESFRI/ERIC and other world-class research infrastructures
HORIZON-INFRA-2026-DEV-01-07 (page 31)
Widening (Pillar IV)
List of call topics and call texts are found in this document:
Horizon Europe Work Programme 2026-2027 11. Widening participation and strengthening the European Research Area (PDF, 1 MB, new tab)